The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is calling for comments on the Centers for Medicare and Medicaid Services’ latest call for input on an advance notice of proposed rule making regarding an international pricing index for Medicare Part B drugs.
In an email, ISPOR says it intends to “comment primarily on general considerations relating to the use of international reference pricing vs. other alternatives such as value-based pricing.”
Individuals are urged to answer a survey on the issue by Dec. 14, 2018.
According to the email, the proposed rule could be published for comment in spring 2019.
To take the survey, click here.